Marrone Bio Innovations Reports Second Quarter 2016 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
Marine Bio (MBII) Reports In-Line Q2 EPS, Enters Microbial Product Development Pact with Albaugh
August 9, 2016 4:46 PM EDTMarine Bio (NASDAQ: MBII) reported Q2 EPS of ($0.28), in-line with the analyst estimate of ($0.28). Revenue for the quarter came in at $5 million versus the consensus estimate of $4.61 million.
Albaugh, LLC and Marrone Bio Innovations, Inc. (MBI) announced the companies have signed an exclusive agreement to develop and market one of MBIs microbial products, a proprietary microbial biopesticide with insecticidal and nematicidal properties, for seed treatment applications.
Dr. Pam Marrone, Founder and... More
